Yong G Peng, MD, PhD, FASE, FASA - Research

Research at a glance

Top areas of exploration

Postoperative Complications , 5 publications
Aortic Valve , 4 publications
Hydrazones , 4 publications
Pyridazines , 4 publications

Research activity

39 publications

161 citations

Why is this important?

Active clinical trials

Phase 3 Trial of PROTHROMPLEX TOTAL for Reversal of Direct Oral Factor Xa Inhibitor-induced Anticoag

The aim of this study is to find out the effects of TAK-330 compared with four-factor prothrombin complex concentrate (4F-PCC) as part of standard treatment other than Prothromplex Total for anticoagulation reversal in participants treated with鈥�

Investigators: T. Everett Jones, Yong G Peng
Status: Accepting Candidates
Ages: 18 Years - N/A
Sexes: All

My publications

39 publications

2025

Unique Treatment of Atrial Fibrillation: Simultaneous Dual Direct-Current Cardioversion in Morbidly Obese Patients.

Cureus

鈥�

2022

Posttraumatic pneumonectomy and management of severely contaminated pleural space.

JTCVS techniques

鈥�

2020

Use of Impella Support in Transcatheter Aortic Valve Replacement for a Patient With Severe Aortic Stenosis and Significantly Reduced Ejection Fraction.

Journal of cardiothoracic and vascular anesthesia

鈥�

2019

Percutaneous mechanical devices for supporting the left ventricular failure.

Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences

鈥�

2018

Levosimendan for Pediatric Anomalous Left Coronary Artery From the Pulmonary Artery Undergoing Repair: A Single-Center Experience.

Frontiers in pediatrics

鈥�

网红黑料